Dr. Vermeulen Lynn SRL

Dr. Vermeulen Lynn reported total assets of 165,326 € at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Jul 2026).

Company number (CBE) 0770.835.244
8940 Wervik
active in Medical specialists activities (NACE 86220)
operating since 07 Jul 2021 (≈ 5 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Vermeulen Lynn shows with a free account.

See the score
Profile
SRL since 2021
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result148,690 €
Equity6,466 €
Cash71,147 €
EBITDA197,350 €
Total assets165,326 €
The line marks its sector median: 72.2% (8672 companies).

Change 2022 → 2025: Equity -94 % Total assets +23 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Vermeulen Lynn's annual accounts

20252024202320222021
Net result148,690 €
Equity6,466 €
Cash71,147 €
EBITDA197,350 €
Total assets165,326 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 20 Jul 2026
  • Year ended 31 Dec 2024filed on 28 Aug 2025
  • Year ended 31 Dec 2023filed on 30 Sep 2024
  • Year ended 31 Dec 2022filed on 29 Sep 2023
  • Year ended 31 Dec 2021filed on 02 Sep 2022

Dr. Vermeulen Lynn's financial analysis

Management and control of Dr. Vermeulen Lynn

1 active director(s) in the register.

Dr. Vermeulen Lynn's shareholders and holdings →

Dr. Vermeulen Lynn's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0770.835.244
VAT number
No VAT activity declared to the CBE
Peppol
Registered · 0208:0770835244 · as of 10 Nov 2026
Legal form
SRL
Incorporated
07 Jul 2021
Registered office
8940 Wervik
Latest accounts
2025 · filed on 20 Jul 2026
Activity
Medical specialists activities (NACE 86220)

Dr. Vermeulen Lynn (SRL) has been based in Wervik since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 148,690 € and equity of 6,466 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Vermeulen Lynn

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Vermeulen Lynn

What is the revenue of Dr. Vermeulen Lynn?

Dr. Vermeulen Lynn files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Vermeulen Lynn?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Vermeulen Lynn. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0770835244. Its company number (CBE) is 0770.835.244.

Where is the registered office of Dr. Vermeulen Lynn?

According to the CBE register, the registered office of Dr. Vermeulen Lynn is in 8940 Wervik.

What is the equity of Dr. Vermeulen Lynn?

At the close of the 2025 financial year, the equity of Dr. Vermeulen Lynn amounts to 6,466 €, a solvency of 3.9% of total assets.

Who manages Dr. Vermeulen Lynn?

The register lists 1 active mandates at Dr. Vermeulen Lynn. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Vermeulen Lynn

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Aug 2026

No credit card, no commitment.

What each plan unlocks →